CARDIFF ONCOLOGY APPOINTS DR. ROGER SIDHU AS CHIEF MEDICAL OFFICER AND ANNOUNCES TIMING FOR THE NEXT UPDATE FROM THE CRDF-004 TRIAL IN FIRST-LINE RAS-MUTATED MCRC
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.